BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26570)

  • 1. Formation of complexes between microsomal cytochrome P-450-Fe(II) and nitrosoarenes obtained by oxidation of arylhydroxylamines or reduction of nitroarenes in situ.
    Mansuy D; Beaune P; Cresteil T; Bacot C; Chottard JC; Gans P
    Eur J Biochem; 1978 May; 86(2):573-9. PubMed ID: 26570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrosoalkanes as Fe(II) ligands in the 455-nm-absorbing cytochrome P-450 complexes formed from nitroalkanes in reducing conditions.
    Mansuy D; Gans P; Chottard JC; Bartoli JF
    Eur J Biochem; 1977 Jun; 76(2):607-15. PubMed ID: 891529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of cytochrome P-450 in the reduction of nitro compounds by rat liver microsomes.
    Harada N; Omura T
    J Biochem; 1980 May; 87(5):1539-54. PubMed ID: 7390998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of benzyl halides by liver microsomes. Formation of 478 NM-absorbing sigma-alkyl-ferric cytochrome P-450 complexes.
    Mansuy D; Fontecave M
    Biochem Pharmacol; 1983 Jun; 32(12):1871-9. PubMed ID: 6882464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct formation of complexes between cytochrome P-450 and nitrosoarenes.
    Fukuto JM; Brady JF; Burstyn JN; VanAtta RB; Valentine JS; Cho AK
    Biochemistry; 1986 May; 25(9):2714-9. PubMed ID: 3013312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosoalkanes as Fe(II) ligands in the hemoglobin and myoglobin complexes formed from nitroalkanes in reducing conditions.
    Mansuy D; Chottard JC; Chottard G
    Eur J Biochem; 1977 Jun; 76(2):617-23. PubMed ID: 891530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of monosubstituted hydrazines and diazenes with rat-liver cytochrome P450. Formation of ferrous-diazene and ferric sigma-alkyl complexes.
    Battioni P; Mahy JP; Delaforge M; Mansuy D
    Eur J Biochem; 1983 Aug; 134(2):241-8. PubMed ID: 6873062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters.
    Larrey D; Tinel M; Letteron P; Geneve J; Descatoire V; Pessayre D
    Biochem Pharmacol; 1986 Jul; 35(13):2213-20. PubMed ID: 3729976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of prostaglandin synthase-iron-nitrosoalkane inhibitory complexes upon in situ oxidation of N-substituted hydroxylamines.
    Mahy JP; Mansuy D
    Biochemistry; 1991 Apr; 30(17):4165-72. PubMed ID: 1902377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of nitric oxide synthase-iron(II) nitrosoalkane complexes: severe restriction of access to the iron(II) site in the presence of tetrahydrobiopterin.
    Renodon A; Boucher JL; Wu C; Gachhui R; Sari MA; Mansuy D; Stuehr D
    Biochemistry; 1998 May; 37(18):6367-74. PubMed ID: 9572852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of nitrosobenzene, phenylhydroxylamine, and aniline in the isolated perfused rat liver.
    Eyer P; Kampffmeyer H; Maister H; Rösch-Oehme E
    Xenobiotica; 1980; 10(7-8):499-516. PubMed ID: 6893777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and disposition of N-hydroxylated metabolites of aniline and nitrobenzene by isolated rat hepatocytes.
    Blaauboer BJ; Van Holsteijn CW
    Xenobiotica; 1983 May; 13(5):295-302. PubMed ID: 6636826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of aromatic nitro compounds with reduced hepatic microsomal cytochrome P-450.
    Sternson LA; Gammans RE
    Drug Metab Dispos; 1975; 3(4):266-74. PubMed ID: 240656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions of prostaglandin H synthase with monosubstituted hydrazines and diazenes. Formation of iron(II)-diazene and iron(III)-sigma-alkyl or iron(III)-sigma-aryl complexes.
    Mahy JP; Gaspard S; Delaforge M; Mansuy D
    Eur J Biochem; 1994 Dec; 226(2):445-57. PubMed ID: 8001562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of the "455 nm absorbing complex" formed during the cytochrome P450 dependent oxidative metabolism of amphetamine.
    Mansuy D; Beaune P; Chottard JC; Bartoli JF; Gans P
    Biochem Pharmacol; 1976 Mar; 25(5):609-12. PubMed ID: 942497
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines. IX. A comparative study with enantiomeric 2-nitroso-1-phenylpropane in microsomes and a reconstituted cytochrome P-450 system from rat liver.
    Paulsen-Sörman U; Jönsson KH; Lindeke B
    Chem Biol Interact; 1988; 67(1-2):49-58. PubMed ID: 3168083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aerobic reduction of Fe(III) complexes by hemoglobin and myoglobin.
    Eguchi LA; Saltman P
    J Biol Chem; 1984 Dec; 259(23):14337-8. PubMed ID: 6548749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of nitrobenzene nitroreductase from Pseudomonas pseudoalcaligenes JS45.
    Somerville CC; Nishino SF; Spain JC
    J Bacteriol; 1995 Jul; 177(13):3837-42. PubMed ID: 7601851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-EDTA stimulated reduction of indicine N-oxide by the hepatic microsomal fraction, isolated hepatocytes, and the intact rat.
    Powis G; Svingen BA; Degraw C
    Biochem Pharmacol; 1982 Feb; 31(3):293-9. PubMed ID: 6280724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH effects on the N-demethylation and formation of the cytochrome P-450 iron II nitrosoalkane complex for erythromycin derivatives.
    Delaforge M; Ladam P; Bouillé G; Benarous JG; Jaouen M; Girault JP
    Chem Biol Interact; 1992 Dec; 85(2-3):215-27. PubMed ID: 1493610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.